Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Oleic acid shows up across pharmaceuticals and nutrition science any time someone looks for a reliable, pharmaceutically pure fatty acid. In injection grade, it carries high standards for purity and traceability. Track the history of this compound through BP, EP, and USP grades, each raising the quality bar and laying out expectations for pharmaceutical manufacturers and clinicians. Lab workers rely on it in parenteral drug formulations, expecting its character to stay consistent from batch to batch. In my experience, a pharmaceutical company sourcing excipients for sterile production always drills down to how and where a compound like this comes together — its farm and plant origins, extraction, and the purification processes that remove unwanted byproducts like peroxides or color bodies. That traceability matters for anyone signing off on raw materials for products patients can rely on in critical treatments.
Oleic acid, with a molecular formula of C18H34O2 and a molecular weight of about 282.47 g/mol, stands out as a monounsaturated omega-9 fatty acid. Transparent, colorless to pale yellow, it pours with an oily touch and a subtly fatty odor that signals purity; off odors mean impurities — something anyone doing QC will notice. It sits as a liquid at room temperature, density hovering around 0.89 g/cm³, and doesn’t turn into a solid until temperatures drop below 13 to 16°C. Melting point matters when a chemist sets up storage or compounds injectables, since precipitation can ruin an emulsion or suspension batch. It’s used as a liquid, and anyone who has handled it knows it clings more than water but feels nothing like a mineral oil — less viscous, more ready to blend, which changes formulation possibilities.
Structurally, oleic acid presents a long hydrocarbon chain with a single cis double bond at the 9th carbon — nothing fancy on the surface, but this one kink in the chain brings important solubility and fluidity that define its role in cell biology and pharmaceutical carriers. The pharma grade means the supplier certifies it meets BP, EP, and USP limits on peroxide value, acid value, unsaponifiable matter, and heavy metals — specs set with safety in mind for injectable use. Compliance with these standards keeps pyrogenicity and reactivity low, a must for parenteral drugs. For teams choosing excipients, the certificate of analysis and validated process stand front and center — and establishing these specs often takes years of paperwork, product development, and regulator back-and-forth.
Manufacturers almost exclusively use oleic acid for injection as a clear, viscous liquid; solid forms like flakes or pearls are rare in this category, although technical and lower-purity grades sometimes arrive in those forms for industrial use. Preparing sterile solutions depends on the liquid staying stable and clear, since crystallization or phase separation triggers batch rejections immediately in any GMP environment. Staff in compounding pharmacies or sterile fill-finish plants look for a liquid that pours without sediment and doesn’t cloud under controlled temperature. Any shift from clear to hazy in storage triggers a full investigation, as I’ve seen first-hand in GMP audits.
International supply chains mean shipping paperwork gets scrutinized. The HS Code for oleic acid often falls under 3823.19, covering industrial fatty acids but with specificity for pharmaceutical and food-grade use documented elsewhere. Accurate classification means the right tariffs and safety paperwork, but more importantly it signals to customs and regulators that this material travels for a high-purity end use. In import-export circles, teams track raw material batches using both HS code and lot numbers — mixing these up can delay deliveries critically needed for drug manufacturing runs. Regulatory teams in pharma settings obsessively track each drum, liter, and batch to enforce traceability, recalls, and supply disruption mitigation.
Most laboratory-trained personnel treat pharmaceutical-grade oleic acid as having low toxicity but moderate irritancy on direct contact — eye or skin exposure stings, inhaling fine droplets feels unpleasant. Regulatory sheets rate it as safe so long as medical, sterile handling practices are followed. Done right, spills clean up with regular absorbents and soap, but no one skips gloves or overlooks secondary containment, especially around sterile fill lines. In terms of chemical reactivity, storage away from strong oxidizers and heat sources keeps oleic acid stable and safe. Every production environment I’ve worked in drives home that even low-hazard materials pose risks when scale goes up; secondary packaging, vented storage, and regular inspections become second nature.
On the raw materials side, oleic acid serves as an emulsifier, penetration enhancer, or solubilizer. These roles shape formulation science, especially when facing poor solubility from high-potency APIs or difficult BCS Class II drugs. In my own experience with formulation labs, tweaking the oleic acid concentration can tip the balance between stable emulsion and phase-separating mess. Oleic acid interacts with both hydrophilic and lipophilic molecules, letting developers fine-tune drug delivery systems—especially in oncology and parenteral nutrition. The choice of pharma-grade means teams can rely on each lot’s reactivity, not worry about batch-to-batch surprises, and keep QbD (quality by design) rationale firmly defensible in regulatory submissions.
Oleic acid for injection, properly sourced and certified, presents little acute toxicity or environmental risk under proper operating conditions, but mistakes in handling — like mixing incompatible excipients or skipping endotoxin testing — can produce unsafe products quickly. Lab techs and pharmacists enforce batch controls: sterility checks, pyrogen tests, pH verification, and sterile filtration track each step before release. Incidents from contaminated or out-of-spec oleic acid, though rare, make headlines and trigger intensive corrective action plans. Safe handling boils down to regular equipment checks, strict documentation, and always confirming supplier credentials against regulatory databases.
In practice, supply chain stress highlights the value of qualified alternate sources for raw materials like oleic acid. Geopolitical issues or plant shutdowns can threaten consistent availability, leading to rushed substitutions that carry risk. I’ve seen development and procurement teams hedge against these problems by pre-qualifying multiple suppliers, demanding detailed batch analytics, and holding regular supplier audits. Investment in supply-chain transparency — including digital batch records, blockchain traceability, and real-time COA verification — gives companies an edge in facing shortages or recalls. Everybody from quality assurance managers to pharmacists benefits from robust oversight, reducing unexpected downtime and regulatory headaches.
Chengguan District, Lanzhou, Gansu, China
